Abiopharma

Riassunto: Suzano annuncia un EBITDA rettificato di 4,7 miliardi di real brasiliani nel secondo trimestre 2026

Suzano meldet für das zweite Quartal 2026 ein bereinigtes EBITDA von 4,7 Milliarden BRL

Suzano annonce un EBITDA ajusté de 4,7 milliards de réaux au deuxième trimestre 2026

Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results

Bitwise To Explore Tokenizing Bitwise Solana Staking ETF (BSOL) With Superstate; Other ETFs May Follow

Silicon Motion Technology Corporation Announces Closing of Upsized Offering of $1,150,000,000 of 0.00% Convertible Senior Notes due 2031

Agora, Inc. Reports Second Quarter 2026 Financial Results

Synchrony Elevates AI Strategy Hiring Nimrod Barak as Chief AI Officer to Accelerate Innovation

Diginex Grows Revenue 77%, Remains Debt-Free as Sustainability RegTech Platform Takes Shape Following Strategic Acquisitions

Verizon readies for Tropical Storm Lala; Offers tips for Hawai’i residents and businesses